Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism

M Donadelli; I Dando; T Zaniboni; C Costanzo; E Dalla Pozza; M T Scupoli; A Scarpa; S Zappavigna; M Marra; A Abbruzzese; M Bifulco; M Caraglia; M Palmieri

doi:10.1038/cddis.2011.36

journal article Apr 28, 2011

Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism

M Donadelli I Dando T Zaniboni C Costanzo E Dalla Pozza M T Scupoli A Scarpa S Zappavigna M Marra A Abbruzzese M Bifulco M Caraglia M Palmieri

Cell Death & Disease Vol. 2 No. 4 pp. e152-e152 · Springer Science and Business Media LLC

View at Publisher Save 10.1038/cddis.2011.36

Topics

No keywords indexed for this article. Browse by subject →

References

40

[1]

Li J, Merl MY, Chabot J, Saif MW . Updates of adjuvant therapy in pancreatic cancer: where are we and where are we going? Highlights from the ‘2010 ASCO Annual Meeting’. Chicago, IL, USA. JOP 2010; 11: 310–312.

[2]

Neoptolemos JP, Cunningham D, Friess H, Bassi C, Stocken DD, Tait DM et al. Adjuvant therapy in pancreatic cancer: historical and current perspectives. Ann Oncol 2003; 14: 675–692. 10.1093/annonc/mdg207

[3]

Burris III HA, Moore MJ, Andersen J, Green MR, Rothenberg ML, Modiano MR et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 1997; 15: 2403–2413. 10.1200/jco.1997.15.6.2403

[4]

Laurent A, Nicco C, Chereau C, Goulvestre C, Alexandre J, Alves A et al. Controlling tumor growth by modulating endogenous production of reactive oxygen species. Cancer Res 2005; 65: 948–956. 10.1158/0008-5472.948.65.3

[5]

Donadelli M, Costanzo C, Beghelli S, Scupoli MT, Dandrea M, Bonora A et al. Synergistic inhibition of pancreatic adenocarcinoma cell growth by trichostatin A and gemcitabine. Biochim Biophys Acta 2007; 1773: 1095–1106. 10.1016/j.bbamcr.2007.05.002

[6]

Casanova ML, Blazquez C, Martinez-Palacio J, Villanueva C, Fernandez-Acenero MJ, Huffman JW et al. Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors. J Clin Invest 2003; 111: 43–50. 10.1172/jci200316116

[7]

De Petrocellis L, Melck D, Palmisano A, Bisogno T, Laezza C, Bifulco M et al. The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation. Proc Natl Acad Sci USA 1998; 95: 8375–8380. 10.1073/pnas.95.14.8375

[8]

Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI . Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 1990; 346: 561–564. 10.1038/346561a0

[9]

Munro S, Thomas KL, Abu-Shaar M . Molecular characterization of a peripheral receptor for cannabinoids. Nature 1993; 365: 61–65. 10.1038/365061a0

[10]

Carracedo A, Gironella M, Lorente M, Garcia S, Guzman M, Velasco G et al. Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress-related genes. Cancer Res 2006; 66: 6748–6755. 10.1158/0008-5472.can-06-0169

[11]

Sarker KP, Obara S, Nakata M, Kitajima I, Maruyama I . Anandamide induces apoptosis of PC-12 cells: involvement of superoxide and caspase-3. FEBS Lett 2000; 472: 39–44. 10.1016/s0014-5793(00)01425-3

[12]

Costa B, Colleoni M . Changes in rat brain energetic metabolism after exposure to anandamide or Delta(9)-tetrahydrocannabinol. Eur J Pharmacol 2000; 395: 1–7. 10.1016/s0014-2999(00)00170-9

[13]

Salazar M, Carracedo A, Salanueva IJ, Hernandez-Tiedra S, Lorente M, Egia A et al. Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells. J Clin Invest 2009; 119: 1359–1372. 10.1172/jci37948

[14]

Yokouchi M, Hiramatsu N, Hayakawa K, Okamura M, Du S, Kasai A et al. Involvement of selective reactive oxygen species upstream of proapoptotic branches of unfolded protein response. J Biol Chem 2008; 283: 4252–4260. 10.1074/jbc.m705951200

[15]

Rutkowski DT, Kaufman RJ . That which does not kill me makes me stronger: adapting to chronic ER stress. Trends Biochem Sci 2007; 32: 469–476. 10.1016/j.tibs.2007.09.003

[16]

Kaufman RJ . Orchestrating the unfolded protein response in health and disease. J Clin Invest 2002; 110: 1389–1398. 10.1172/jci0216886

[17]

Schonthal AH . Endoplasmic reticulum stress and autophagy as targets for cancer therapy. Cancer Lett 2009; 275: 163–169. 10.1016/j.canlet.2008.07.005

[18]

ER Stress Triggers Apoptosis by Activating BH3-Only Protein Bim

Hamsa Puthalakath, Lorraine A. O'Reilly, Priscilla Gunn et al.

Cell 2007 10.1016/j.cell.2007.04.027

[19]

Rouschop KM, van den Beucken T, Dubois L, Niessen H, Bussink J, Savelkouls K et al. The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5. J Clin Invest 2010; 120: 127–141. 10.1172/jci40027

[20]

Kondo Y, Kondo S . Autophagy and cancer therapy. Autophagy 2006; 2: 85–90. 10.4161/auto.2.2.2463

[21]

Massi P, Vaccani A, Bianchessi S, Costa B, Macchi P, Parolaro D . The non-psychoactive cannabidiol triggers caspase activation and oxidative stress in human glioma cells. Cell Mol Life Sci 2006; 63: 2057–2066. 10.1007/s00018-006-6156-x

[22]

Biederbick A, Kern HF, Elsasser HP . Monodansylcadaverine (MDC) is a specific in vivo marker for autophagic vacuoles. Eur J Cell Biol 1995; 66: 3–14.

[23]

Xie S, Furjanic MA, Ferrara JJ, McAndrew NR, Ardino EL, Ngondara A et al. The endocannabinoid system and rimonabant: a new drug with a novel mechanism of action involving cannabinoid CB1 receptor antagonism – or inverse agonism--as potential obesity treatment and other therapeutic use. J Clin Pharm Ther 2007; 32: 209–231. 10.1111/j.1365-2710.2007.00817.x

[24]

Krylatov AV, Maslov LN, Lasukova OV, Pertwee RG . Cannabinoid receptor antagonists SR141716 and SR144528 exhibit properties of partial agonists in experiments on isolated perfused rat heart. Bull Exp Biol Med 2005; 139: 558–561. 10.1007/s10517-005-0344-9

[25]

Bifulco M, Grimaldi C, Gazzerro P, Pisanti S, Santoro A . Rimonabant: just an antiobesity drug? Current evidence on its pleiotropic effects. Mol Pharmacol 2007; 71: 1445–1456. 10.1124/mol.106.033118

[26]

Bifulco M, Laezza C, Valenti M, Ligresti A, Portella G, V DIM . A new strategy to block tumor growth by inhibiting endocannabinoid inactivation. Faseb J 2004; 18: 1606–1608. 10.1096/fj.04-1754fje

[27]

Donadelli M, Dalla Pozza E, Costanzo C, Scupoli MT, Piacentini P, Scarpa A et al. Increased stability of P21(WAF1/CIP1) mRNA is required for ROS/ERK-dependent pancreatic adenocarcinoma cell growth inhibition by pyrrolidine dithiocarbamate. Biochim Biophys Acta 2006; 1763: 917–926. 10.1016/j.bbamcr.2006.05.015

[28]

Donadelli M, Dalla Pozza E, Scupoli MT, Costanzo C, Scarpa A, Palmieri M . Intracellular zinc increase inhibits p53(−/−) pancreatic adenocarcinoma cell growth by ROS/AIF-mediated apoptosis. Biochim Biophys Acta 2009; 1793: 273–280. 10.1016/j.bbamcr.2008.09.010

[29]

Shi Y, Zou M, Baitei EY, Alzahrani AS, Parhar RS, Al-Makhalafi Z et al. Cannabinoid 2 receptor induction by IL-12 and its potential as a therapeutic target for the treatment of anaplastic thyroid carcinoma. Cancer Gene Ther 2008; 15: 101–107. 10.1038/sj.cgt.7701101

[30]

Borner C, Bedini A, Hollt V, Kraus J . Analysis of promoter regions regulating basal and interleukin-4-inducible expression of the human CB1 receptor gene in T lymphocytes. Mol Pharmacol 2008; 73: 1013–1019. 10.1124/mol.107.042945

[31]

Arlt A, Gehrz A, Muerkoster S, Vorndamm J, Kruse ML, Folsch UR et al. Role of NF-kappaB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death. Oncogene 2003; 22: 3243–3251. 10.1038/sj.onc.1206390

[32]

Maiuri MC, Zalckvar E, Kimchi A, Kroemer G . Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol 2007; 8: 741–752. 10.1038/nrm2239

[33]

Boya P, Gonzalez-Polo RA, Casares N, Perfettini JL, Dessen P, Larochette N et al. Inhibition of macroautophagy triggers apoptosis. Mol Cell Biol 2005; 25: 1025–1040. 10.1128/mcb.25.3.1025-1040.2005

[34]

Mukubou H, Tsujimura T, Sasaki R, Ku Y . The role of autophagy in the treatment of pancreatic cancer with gemcitabine and ionizing radiation. Int J Oncol 2010; 37: 821–828.

[35]

Wu BX, Zeidan YH, Hannun YA . Downregulation of neutral ceramidase by gemcitabine: implications for cell cycle regulation. Biochim Biophys Acta 2009; 1791: 730–739. 10.1016/j.bbalip.2009.03.012

[36]

Galve-Roperh I, Sanchez C, Cortes ML, Gomez del Pulgar T, Izquierdo M, Guzman M . Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation. Nat Med 2000; 6: 313–319. 10.1038/73171

[37]

Garcia-Ruiz C, Colell A, Mari M, Morales A, Fernandez-Checa JC . Direct effect of ceramide on the mitochondrial electron transport chain leads to generation of reactive oxygen species. Role of mitochondrial glutathione. J Biol Chem 1997; 272: 11369–11377. 10.1074/jbc.272.17.11369

[38]

Moore PS, Sipos B, Orlandini S, Sorio C, Real FX, Lemoine NR et al. Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, p53, p16 and DPC4/Smad4. Virchows Arch 2001; 439: 798–802. 10.1007/s004280100474

[39]

Chou TC, Talalay P . Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 1984; 22: 27–55. 10.1016/0065-2571(84)90007-4

[40]

Meschini S, Condello M, Calcabrini A, Marra M, Formisano G, Lista P et al. The plant alkaloid voacamine induces apoptosis-independent autophagic cell death on both sensitive and multidrug resistant human osteosarcoma cells. Autophagy 2008; 4: 1020–1033. 10.4161/auto.6952

Cited By

192

Molecular mechanisms and therapeutic strategies in overcoming chemotherapy resistance in cancer

Yixiang Gu, Ruifeng Yang · 2025

Molecular Biomedicine

Combination of Cannabidiol with Cisplatin or Paclitaxel Analysis Using the Chou–Talalay Method and Chemo-Sensitization Evaluation in Platinum-Resistant Ovarian Cancer Cells

Jana Ismail, Wassim Shebaby · 2025

Biomedicines

Phytocannabinoids as Chemotherapy Adjuncts—A Review for Users

Gerhard Nahler · 2024

Onco

Potential, Limitations and Risks of Cannabis-Derived Products in Cancer Treatment

Herman J. Woerdenbag, Peter Olinga · 2023

Cancers

ATDC binds to KEAP1 to drive NRF2-mediated tumorigenesis and chemoresistance in pancreatic cancer

Vinee Purohit, Lidong Wang · 2021

Genes & Development

Cannabinoids as therapeutic agents in cancer: current status and future implications

Bandana Chakravarti, Janani Ravi · 2014

Oncotarget

Metrics

192

Citations

40

References

Details

Published: Apr 28, 2011
Vol/Issue: 2(4)
Pages: e152-e152
License: View

Authors

Cite This Article

M Donadelli, I Dando, T Zaniboni, et al. (2011). Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism. Cell Death & Disease, 2(4), e152-e152. https://doi.org/10.1038/cddis.2011.36

Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism

You May Also Like